drugset / Trial / NCT02118376
Effects of GLP-1 Receptor Agonist on Fat Redistribution and Inflammatory Status
NaSingle-groupOpen-labelTreatment
Summary
GLP-1 receptor agonists promote fat redistribution in obese women with type 2 diabetes, reduce liver fat content, improve the inflammation state
Timeline
- Start
- 2014-08
- Primary completion
- 2014-12
- Completion
- 2014-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Exenatide | Peptide | 5 ug | Subcutaneous |